Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Sacituzumab_govitecan> ?p ?o }
Showing triples 1 to 31 of
31
with 100 triples per page.
- Sacituzumab_govitecan abstract "Sacituzumab govitecan (previously IMMU-132) is an antibody-drug conjugate being investigated as a treatment for cancers such as pancreatic cancers, small-cell lung cancer(SCLC) and triple-negative breast cancer.It is a conjugate of the humanized anti-Trop-2 monoclonal antibody (hRS7) with SN-38, the active metabolite of irinotecan.".
- Sacituzumab_govitecan wikiPageExternalLink Public.Listing.display.html.
- Sacituzumab_govitecan wikiPageID "47556310".
- Sacituzumab_govitecan wikiPageLength "2409".
- Sacituzumab_govitecan wikiPageOutDegree "13".
- Sacituzumab_govitecan wikiPageRevisionID "705176173".
- Sacituzumab_govitecan wikiPageWikiLink Antibody-drug_conjugate.
- Sacituzumab_govitecan wikiPageWikiLink Breakthrough_therapy.
- Sacituzumab_govitecan wikiPageWikiLink Category:Antibody-drug_conjugate.
- Sacituzumab_govitecan wikiPageWikiLink Category:Cancer_treatments.
- Sacituzumab_govitecan wikiPageWikiLink Gastrointestinal_cancer.
- Sacituzumab_govitecan wikiPageWikiLink HRS7.
- Sacituzumab_govitecan wikiPageWikiLink Irinotecan.
- Sacituzumab_govitecan wikiPageWikiLink Monoclonal_antibody.
- Sacituzumab_govitecan wikiPageWikiLink Pancreatic_cancer.
- Sacituzumab_govitecan wikiPageWikiLink SN-38.
- Sacituzumab_govitecan wikiPageWikiLink Small-cell_carcinoma.
- Sacituzumab_govitecan wikiPageWikiLink TACSTD2.
- Sacituzumab_govitecan wikiPageWikiLink Triple-negative_breast_cancer.
- Sacituzumab_govitecan wikiPageWikiLinkText "Sacituzumab govitecan".
- Sacituzumab_govitecan wikiPageWikiLinkText "sacituzumab govitecan".
- Sacituzumab_govitecan wikiPageUsesTemplate Template:Pharma-stub.
- Sacituzumab_govitecan wikiPageUsesTemplate Template:Reflist.
- Sacituzumab_govitecan subject Category:Antibody-drug_conjugate.
- Sacituzumab_govitecan subject Category:Cancer_treatments.
- Sacituzumab_govitecan hypernym Conjugate.
- Sacituzumab_govitecan type Drug.
- Sacituzumab_govitecan comment "Sacituzumab govitecan (previously IMMU-132) is an antibody-drug conjugate being investigated as a treatment for cancers such as pancreatic cancers, small-cell lung cancer(SCLC) and triple-negative breast cancer.It is a conjugate of the humanized anti-Trop-2 monoclonal antibody (hRS7) with SN-38, the active metabolite of irinotecan.".
- Sacituzumab_govitecan label "Sacituzumab govitecan".
- Sacituzumab_govitecan wasDerivedFrom Sacituzumab_govitecan?oldid=705176173.
- Sacituzumab_govitecan isPrimaryTopicOf Sacituzumab_govitecan.